Correction to: Specific Susceptibility to COVID-19 in Adults with Down Syndrome
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
---|---|
Enthalten in: |
Neuromolecular medicine - 23(2021), 4 vom: 19. Nov., Seite 574-575 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Illouz, Tomer [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
Anmerkungen: |
© Springer Science+Business Media, LLC, part of Springer Nature 2021 |
---|
doi: |
10.1007/s12017-021-08695-7 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC2077521627 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC2077521627 | ||
003 | DE-627 | ||
005 | 20230512141227.0 | ||
007 | tu | ||
008 | 221220s2021 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1007/s12017-021-08695-7 |2 doi | |
035 | |a (DE-627)OLC2077521627 | ||
035 | |a (DE-He213)s12017-021-08695-7-p | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
100 | 1 | |a Illouz, Tomer |e verfasserin |4 aut | |
245 | 1 | 0 | |a Correction to: Specific Susceptibility to COVID-19 in Adults with Down Syndrome |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a © Springer Science+Business Media, LLC, part of Springer Nature 2021 | ||
700 | 1 | |a Biragyn, Arya |4 aut | |
700 | 1 | |a Frenkel-Morgenstern, Milana |4 aut | |
700 | 1 | |a Weissberg, Orly |4 aut | |
700 | 1 | |a Gorohovski, Alessandro |4 aut | |
700 | 1 | |a Merzon, Eugene |4 aut | |
700 | 1 | |a Green, Ilan |4 aut | |
700 | 1 | |a Iulita, Florencia |4 aut | |
700 | 1 | |a Flores-Aguilar, Lisi |4 aut | |
700 | 1 | |a Dierssen, Mara |4 aut | |
700 | 1 | |a De Toma, Ilario |4 aut | |
700 | 1 | |a Lifshitz, Hefziba |4 aut | |
700 | 1 | |a Antonarakis, Stylianos E. |4 aut | |
700 | 1 | |a Yu, Eugene |4 aut | |
700 | 1 | |a Herault, Yann |4 aut | |
700 | 1 | |a Potier, Marie-Claude |4 aut | |
700 | 1 | |a Botté, Alexandra |4 aut | |
700 | 1 | |a Roper, Randall |4 aut | |
700 | 1 | |a Sredni, Benjamin |4 aut | |
700 | 1 | |a Sarid, Ronit |4 aut | |
700 | 1 | |a London, Jacqueline |4 aut | |
700 | 1 | |a Mobley, William |4 aut | |
700 | 1 | |a Strydom, Andre |4 aut | |
700 | 1 | |a Okun, Eitan |0 (orcid)0000-0001-8474-1487 |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Neuromolecular medicine |d Springer US, 2002 |g 23(2021), 4 vom: 19. Nov., Seite 574-575 |w (DE-627)346831865 |w (DE-600)2077809-0 |w (DE-576)518182851 |x 1535-1084 |7 nnns |
773 | 1 | 8 | |g volume:23 |g year:2021 |g number:4 |g day:19 |g month:11 |g pages:574-575 |
856 | 4 | 1 | |u https://doi.org/10.1007/s12017-021-08695-7 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
951 | |a AR | ||
952 | |d 23 |j 2021 |e 4 |b 19 |c 11 |h 574-575 |